Apr 15 |
RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026
|
Apr 5 |
RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024
|
Mar 12 |
RenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024
|
Mar 8 |
RenovoRx promotes Leesa Gentry to chief clinical officer
|
Mar 8 |
RenovoRx Highlights Key Leadership Promotions
|
Feb 6 |
RenovoRx CEO Issues Letter to Shareholders
|
Jan 29 |
RenovoRx closes $6.1M private placement
|
Jan 29 |
RenovoRx Closes $6.1 Million Private Placement
|
Dec 21 |
RenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct Cancer
|
Dec 19 |
RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
|